PricewaterhouseCoopers: Behind the numbers: Medical cost trends for 2011
Generic drugs, the normalization of COBRA costs, and employees paying more out-of-pocket costs will bring down employers' cost of healthcare next year.
6/15/2010
Medical costs in 2011 for employers will decrease slightly from 9.5 percent to 9 percent. The drop results from the proliferation of generic drugs, normalization of COBRA costs, and employees paying more out-of-pocket costs for medical care.
Healthcare reform's biggest changes will take effect in 2014. Some factors that will influence healthcare include a requirement that forces insurance companies to cover dependents to age 26, no lifetime limits on coverage, and subjection to medical loss ratios. As a result, insurance companies, providers, and pharmaceutical companies may change their services, prices, products, and policies. Anticipation of higher demand may push prices up.
The full repercussions of healthcare reform will play out over a decade, PwC says. Long-term changes will include reducing cost-shifting from the uninsured, changing the payment system for providers, creating new markets for health insurance, and an excise tax on high premium plans starting in 2018.
Project Announcements
Acoustical Sheetmetal Company Expands Virginia Beach, Virginia, Operations
06/17/2025
iCapital To Expand Salt Lake County, Utah, Operations
06/17/2025
ACS Manufacturing Expands Davis County, Utah, Operations
06/17/2025
JetZero Plans Greensboro, North Carolina, Headquarters-Production Operations
06/17/2025
Commercial Specialty Truck Holdings Expands Cynthiana, Kentucky, Operations
06/17/2025
Berner International Expands Shenango Township, Pennsylvania, Manufacturing Operations
06/16/2025
Most Read
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Navigating the new era of SCIF construction
Q1 2025
-
Get Your Mega Site ‘Project Ready’
Q2 2025